Digital automation of transdermal drug delivery with high spatiotemporal resolution

Yihang Wang,Zeka Chen,Brayden Davis,Will Lipman,Sicheng Xing,Lin Zhang,Tian Wang,Priyash Hafiz,Wanrong Xie,Zijie Yan,Zhili Huang,Juan Song,Wubin Bai

DOI: https://doi.org/10.1038/s41467-023-44532-0

IF: 16.6

2024-01-14

Nature Communications

Abstract:Transdermal drug delivery is of vital importance for medical treatments. However, user adherence to long-term repetitive drug delivery poses a grand challenge. Furthermore, the dynamic and unpredictable disease progression demands a pharmaceutical treatment that can be actively controlled in real-time to ensure medical precision and personalization. Here, we report a spatiotemporal on-demand patch (SOP) that integrates drug-loaded microneedles with biocompatible metallic membranes to enable electrically triggered active control of drug release. Precise control of drug release to targeted locations (<1 mm 2 ), rapid drug release response to electrical triggers (<30 s), and multi-modal operation involving both drug release and electrical stimulation highlight the novelty. Solution-based fabrication ensures high customizability and scalability to tailor the SOP for various pharmaceutical needs. The wireless-powered and digital-controlled SOP demonstrates great promise in achieving full automation of drug delivery, improving user adherence while ensuring medical precision. Based on these characteristics, we utilized SOPs in sleep studies. We revealed that programmed release of exogenous melatonin from SOPs improve sleep of mice, indicating potential values for basic research and clinical treatments.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper attempts to address the issues of long-term repeat medication adherence and dynamic personalized dosing needs in transdermal drug delivery. Specifically, existing drug delivery devices are inadequate in achieving long-term automated and precise control of drug release. This is particularly important in chronic disease management, where a technology capable of real-time active control of drug release is needed to ensure medical precision and personalized treatment. The paper proposes a spatiotemporal on-demand patch (SOP), which integrates microneedles with drugs and a biocompatible metal membrane, enabling precise control of drug release through electrical triggering.

The main feature of the SOP is its ability to precisely control drug release within an area of less than 1 square millimeter and to respond quickly to electrical trigger signals within 30 seconds. Additionally, the SOP supports multiple operating modes, including drug release and electrical stimulation. The solution manufacturing technology ensures the high customizability and scalability of the SOP, allowing it to adapt to different pharmaceutical needs. The wirelessly powered and digitally controlled SOP demonstrates great potential in achieving fully automated drug delivery, helping to improve patient adherence and ensure medical precision. Based on these characteristics, researchers utilized the SOP in sleep studies and found that programmed release of exogenous melatonin could improve the sleep quality of mice, showing its potential value in both basic research and clinical treatment.